UCSF Bay Area Center for AIDS Research
@UCSF_CFAR
Followers
600
Following
357
Media
123
Statuses
1K
UCSF Bay Area Center for AIDS Research (CFAR) coordinates a robust program focused on interdisciplinary research in HIV disease. @NIH funded, housed @UCSF
San Francisco, CA
Joined July 2014
Registration Now Open! Annual Mentoring the Mentors Workshop for HIV Researchers Aldea Center on Mount Sutro, San Francisco Tuesday and Wednesday, January 13th and 14th, 2026 Registration deadline: October 31, 2025 https://t.co/gWbdFnkzTO
0
0
1
In EPITalk: Behind the Paper (@EPITalk_BTP) a podcast series from the Annals of Epidemiology journal, host (and journal Editor-in-Chief) Patrick Sullivan highlights UCSF-Bay Area CFAR’s Mentoring the Mentors Workshop during the conversation in their latest episode latest episode
0
1
2
Community Forum 5/11: Fostering Trust in Healthcare- Confronting Bias of Race, Gender and Sexual Orientation Saturday, May 11, 2024 11AM-4PM Register here: https://t.co/dBiVNaH5GW
0
1
0
April CFAR Seminar Sara Gianella Weibel + CFAR Excellence Awards Wednesday, April 10, 2024 9:35AM - 11:30AM PT Carr Auditorium, ZSFG - Building 3 and Via Zoom https://t.co/dRO4stUCGS
0
0
1
Ward 86 Job: Apply for this wonderful job opportunity in our Division at @UCSF . I am the Medical Director for Ward 86 HIV clinic here- wonderful place to work and with publicly-insured patients- we are innovative - apply for Associate Medical Director https://t.co/exP8X2ACgW
0
7
21
Special CFAR/Center for TB Joint Seminar: Neela D. Goswami + Payam Nahid 3/20/2024 https://t.co/RSLpM0CKCU
0
0
0
March 2024 Funding Round Up https://t.co/rWtNNkmVZc
0
0
0
DoxyPEP: Strategy by which men-who-have-with-men (MSM) & transgender women can take doxycycline as post-exposure prophylaxis after sex to prevent syphilis & chlamydia (gonorrhea needs vax). Astounding city-wide data from San Francisco -50% drop in both with DoxyPEP guidance.
DoxyPEP Rollout Leads to Drop in STIs in San Francisco @KeckMedicineUSC @uscpphs
0
3
9
Join us on 3/21 at 5PM EST via Zoom for the next #EmoryCFAR Synergy Seminar! Steve Grinspoon (@SteveGrinspoon) & Souheil Younes (@SouheilYounes) will present #HIV research updates for clinicians & virologists. RSVP for this cross-disciplinary session: https://t.co/iYS9ErMm72
0
4
5
LEN/CAB: Yes, we have been calling for a trial of lenacapavir/cabotegravir in low-and-middle-income countries because long-acting ART needed there & there is NNRTI resistance; we assembled this case series to help make this call- shows good efficacy
#CROI2024 @MonicaGandhi9 & colleagues call for a Trial of a long acting combination of #lenacapavir + #Cabotegravir LEN/CAB for those with NNRTI resistance and a requirement for non-oral treatment
0
1
2
Will definitely incorporate all the exciting new data on long-acting ART from #CROI2024 into this talk!
Dr. @MonicaGandhi9 will present best practices in incorporating long-acting agents into clinical practice and discuss potential pitfalls of these treatments and strategies for mitigating them. Register to attend at https://t.co/tlAOdlhjAs.
0
3
10
2024-2025 UCGHI GloCal Health Fellowship Informational Webinar September 27, 2023 7:00AM PT Register at: https://t.co/OHTOGoAPdJ
0
0
0
ENDEMIC: COVID will never be over so important to keep on developing biomedical advances to combat it. This is a middle-ground book to help quell the tension over the COVID response so rampant in the news/internet as we confront a non-eradicable virus. https://t.co/JTJKXS7TvK
9
12
55
N3C Emerging Issues (Virtual) Town Hall PrEP, Doxy PEP and Cisgender Women Thursday, August 24, 2023 3:00-4:30PM PT | 6:00-7:030PM ET Register here: https://t.co/Va7q77Gpn2 Panelists: Connie Celum, MD, MPH Arianne Morrison, MD Martha Sichone Cameron, MPH Cory Roroya
0
1
4
14th International Workshop on HIV & Aging HIV & Aging 2023 October 26-27,2023 Washington DC, United States Format: Hybrid Registration (Early Fee Deadline: 26 July 2023) Abstract Submission (Deadline: 4 August 2023) Website: https://t.co/PobmCthzQc
0
0
2
The new UCSF-Bay Area CFAR website is live! https://t.co/Q4i7E1QgzK
0
0
1